← Open Payments lookup

EMMANUEL ENOKPA: Open Payments

NPI 1063539500 · GERMANTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$702 in 36 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $702

Food & beverage: $702
CompanyPaymentsAmount
Lilly USA, LLC8$118
Novo Nordisk Inc4$99
Sumitomo Pharma America, Inc.4$88
Corcept Therapeutics2$69
AstraZeneca Pharmaceuticals LP4$64
Astellas Pharma US Inc2$45
Otsuka America Pharmaceutical, Inc.2$33
PFIZER INC.2$32
Esperion Therapeutics, Inc.2$31
Organogenesis Inc.1$30

Products named: GEMTESA, MOUNJARO, Korlym, BREZTRI, Wegovy, JARDIANCE, Veozah, Rybelsus.

Industry payments across MD — which companies pay providers there.